Langes K, Bleifeld W, Mathey D G, Kuck K H
Abteilung Kardiologie, Universitäts-Krankenhaus Eppendorf, Hamburg.
Klin Wochenschr. 1989 Dec 4;67(23):1199-204. doi: 10.1007/BF01716207.
For the purposes of the European double blind and randomized study 27 patients with acute myocardial infarction underwent thrombolysis with rt-PA (60 mg over 90 minutes i.v.) or placebo. To evaluate whether arrhythmias, especially ventricular arrhythmias indicate coronary reperfusion after thrombolysis a 24 hour Holter monitoring was performed from the beginning of the rt-PA or placebo infusion. Typical reperfusion arrhythmias were thought to be idioventricular rhythms (rate less than 110/min), ventricular tachycardia (rate greater than 110/min) or bradycardic rhythm disturbances (rate less than 50/min). The effect of thrombolysis on reperfusion of the infarct related artery was evaluated 90 minutes after the infusion by coronary angiography. After 90 minutes of rt-PA or placebo infusion in 16/16 patients treated with rt-PA and 2/11 patients, who received placebo, was the infarct artery patent. 16/18 patients with a patent artery presented a total of 105 arrhythmic events. 47% of the arrhythmias obviously due to reperfusion were classified as idioventricular rhythms. In contrast only 3/9 patients with an occluded infarct artery presented 25 arrhythmic events. The time of occurrence was not different during the running rt-PA infusion compared to placebo. The following interval up to 24 hours showed no difference in incidence and type of the arrhythmias. No relationship was found between reperfusion arrhythmias and salvage of myocardium during 90 minutes of rt-PA or placebo infusion.
为进行欧洲双盲随机研究,27例急性心肌梗死患者接受了rt-PA溶栓治疗(静脉注射60mg,持续90分钟)或安慰剂治疗。为评估心律失常,尤其是室性心律失常是否表明溶栓后冠状动脉再灌注,从开始输注rt-PA或安慰剂起进行了24小时动态心电图监测。典型的再灌注心律失常被认为是心室自身节律(心率小于110次/分钟)、室性心动过速(心率大于110次/分钟)或缓慢性心律失常(心率小于50次/分钟)。输注90分钟后通过冠状动脉造影评估溶栓对梗死相关动脉再灌注的效果。在输注rt-PA或安慰剂90分钟后,接受rt-PA治疗的16/16例患者和接受安慰剂治疗的2/11例患者的梗死动脉通畅。16/18例梗死动脉通畅的患者共出现105次心律失常事件。明显由再灌注引起的心律失常中,47%被归类为心室自身节律。相比之下,梗死动脉闭塞的9/9例患者中只有3例出现25次心律失常事件。与安慰剂相比,在输注rt-PA期间心律失常的发生时间没有差异。在接下来长达24小时的时间段内,心律失常的发生率和类型也没有差异。在输注rt-PA或安慰剂的90分钟内,未发现再灌注心律失常与心肌挽救之间存在关联。